Evidence map›Paper›PMID 42645430›Full record

ArticleAntibodies (Basel, Switzerland)2026

Real-World Effectiveness of Secukinumab in Congenital Ichthyoses: A Retrospective Monocentric Case Series.

Orsola Crespi, Umberto Santaniello, Luca Cangialosi, Ambra Bonvicino, Michela Ortoncelli, Francois Rosset, Luca Mastorino, Simone Ribero, Pietro Quaglino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibodies (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Orsola CrespiDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.ORCID 0009-0001-9270-1204
Umberto SantanielloDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.ORCID 0009-0008-7728-6832
Luca CangialosiDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.
Ambra BonvicinoDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.
Michela OrtoncelliDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.
Francois RossetDepartment of Dermatology, Beauregard Hospital, Azienda USL della Valle d'Aosta, Via L. Vaccari 5, 11100 Aosta, Italy.ORCID 0000-0002-1655-0395
Luca MastorinoDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.ORCID 0000-0001-7386-3219
Simone RiberoDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-0098-1406
Pietro QuaglinoDermatologic Clinic, Department of Medical Science, University of Turin, 10126 Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

congenital ichthyosisIL-17 inhibitionlamellar ichthyosisreal-world evidencesecukinumab

Identifiers

PMID42645430
PMCPMC13509879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.